Methylnaltrexone for Treatment of Opiate-Induced Constipation in the Intensive Care Unit
NCT01050595
·
clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
80
Enrollment
OTHER
Sponsor class
Conditions
Opioid-induced Constipation
Interventions
DRUG:
Methylnaltrexone Bromide
DRUG:
Placebo-Normal Saline
Sponsor
St. John Health System, Michigan